Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study
V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), T. Karampitsakos (Athens, Greece), M. Ntassiou (Athens, Greece), E. Avdoula (Athens, Greece), A. Trachalaki (Athens, Greece), K. Antoniou (Athens, Greece), D. Bouros (Athens, Greece)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), T. Karampitsakos (Athens, Greece), M. Ntassiou (Athens, Greece), E. Avdoula (Athens, Greece), A. Trachalaki (Athens, Greece), K. Antoniou (Athens, Greece), D. Bouros (Athens, Greece). Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study. 737
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: